HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Argiris Symeonidis Selected Research

Bortezomib (Velcade)

1/2024Autophagy and oxidative stress modulation mediate Bortezomib resistance in prostate cancer.
9/2019Randomized phase III study (ADMYRE) of plitidepsin in combination with dexamethasone vs. dexamethasone alone in patients with relapsed/refractory multiple myeloma.
2/2014Treatment with bortezomib-based regimens improves overall response and predicts for survival in patients with primary or secondary plasma cell leukemia: Analysis of the Greek myeloma study group.
6/2011No significant improvement in the outcome of patients with Waldenström's macroglobulinemia treated over the last 25 years.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Argiris Symeonidis Research Topics

Disease

30Myelodysplastic Syndromes (Myelodysplastic Syndrome)
02/2024 - 07/2005
18Multiple Myeloma
01/2024 - 08/2010
9Neoplasms (Cancer)
01/2024 - 01/2004
6Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2024 - 04/2009
6Anemia
12/2018 - 01/2004
5Disease Progression
10/2023 - 11/2013
5Hemoglobinopathies
11/2020 - 10/2017
4Thrombocytopenia (Thrombopenia)
10/2023 - 12/2008
4Thalassemia
02/2021 - 10/2017
4Lymphoma (Lymphomas)
11/2020 - 04/2009
3Hematologic Neoplasms (Hematological Malignancy)
01/2024 - 07/2012
3Pneumonia (Pneumonitis)
10/2023 - 01/2021
3Neutropenia
10/2023 - 01/2021
3Chronic Myelomonocytic Leukemia (Leukemia, Chronic Myelomonocytic)
01/2022 - 01/2017
3beta-Thalassemia (Cooley's Anemia)
01/2019 - 06/2015
2Heart Failure
02/2024 - 02/2022
2Iron Overload
02/2024 - 07/2003
2Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2024 - 06/2011
2Thrombotic Thrombocytopenic Purpura
01/2023 - 12/2008
2Leukemia
01/2022 - 11/2020
2Sickle Cell Anemia (Hemoglobin S Disease)
10/2018 - 10/2017
2Hypercalcemia (Milk Alkali Syndrome)
11/2017 - 11/2011
2Fibrosis (Cirrhosis)
06/2015 - 02/2011
2Non-Hodgkin Lymphoma (Lymphosarcoma)
11/2013 - 11/2010
2Type 2 Diabetes Mellitus (MODY)
02/2006 - 07/2003
1Prostatic Neoplasms (Prostate Cancer)
01/2024
1Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
01/2024
1Bone Marrow Failure Disorders
10/2023
1Sepsis (Septicemia)
10/2023
1Campylobacter Infections (Campylobacter Infection)
10/2023
1Septic Shock (Toxic Shock Syndrome)
10/2023
1Plasmacytoma
11/2022
1Pancytopenia
02/2022
1COVID-19
02/2022
1Myeloproliferative Disorders (Myeloproliferative Disorder)
01/2022
1Cytopenia
08/2021
1Splenomegaly
08/2021
1Pyogenic Granuloma
01/2021
1Respiratory Tract Infections (Respiratory Tract Infection)
01/2021
1POEMS Syndrome (Syndrome, POEMS)
11/2019
1Smoldering Multiple Myeloma
11/2019

Drug/Important Bio-Agent (IBA)

14Azacitidine (5 Azacytidine)FDA Link
01/2022 - 02/2017
10Dexamethasone (Maxidex)FDA LinkGeneric
10/2023 - 01/2014
9Lenalidomide (CC 5013)FDA Link
01/2024 - 01/2014
6IronIBA
02/2024 - 07/2003
6pomalidomideIBA
10/2023 - 01/2021
6Biomarkers (Surrogate Marker)IBA
01/2023 - 10/2017
5Proteasome InhibitorsIBA
01/2024 - 01/2021
5daratumumabIBA
10/2023 - 01/2021
5Hydroxyurea (Hydrea)FDA LinkGeneric
01/2022 - 10/2017
4Bortezomib (Velcade)FDA Link
01/2024 - 06/2011
4L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
11/2013 - 01/2004
3Fetal Hemoglobin (Hemoglobin F)IBA
11/2020 - 10/2017
2Proteasome Endopeptidase Complex (Proteasome)IBA
01/2024 - 12/2023
2Messenger RNA (mRNA)IBA
01/2022 - 06/2019
2Hemoglobins (Hemoglobin)IBA
10/2018 - 01/2004
2Proteins (Proteins, Gene)FDA Link
05/2011 - 01/2004
2technetium Tc 99m depreotide (Tc-99m depreotide)IBA
11/2010 - 12/2008
1Chelating AgentsIBA
02/2024
1DeferasiroxFDA Link
02/2024
1venetoclaxIBA
01/2024
1UbiquitinIBA
01/2024
1Reactive Oxygen Species (Oxygen Radicals)IBA
12/2023
1caplacizumabIBA
01/2023
1DNA (Deoxyribonucleic Acid)IBA
12/2022
1EnzymesIBA
12/2022
1isatuximabIBA
11/2022
1carfilzomibIBA
11/2022
1melflufenIBA
02/2022
1pevonedistatIBA
01/2022
1Ribonucleotide Reductases (Ribonucleotide Reductase)IBA
01/2022
1BI 6727IBA
08/2021
1Phosphotransferases (Kinase)IBA
08/2021
1Cytarabine (Cytosar-U)FDA LinkGeneric
08/2021
1Lipoproteins (Lipoprotein)IBA
01/2021
1Transcription Factors (Transcription Factor)IBA
11/2020
1plitidepsin (aplidine)IBA
09/2019
1Thalidomide (Thalomid)FDA Link
09/2019
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2019
1HematinicsIBA
12/2018
1Indicators and Reagents (Reagents)IBA
10/2018
1Transferrin (beta 2 Transferrin)IBA
01/2018
1Transferrin Receptors (Transferrin Receptor)IBA
01/2018
1Growth Differentiation Factor 15IBA
01/2018
1CalciumIBA
11/2017
1GlobinsIBA
10/2017
1HerbicidesIBA
08/2017
1InsecticidesIBA
08/2017

Therapy/Procedure

20Therapeutics
01/2024 - 04/2009
5Drug Therapy (Chemotherapy)
01/2024 - 07/2012
4Stem Cell Transplantation
10/2015 - 04/2009
3Chelation Therapy (Therapy, Chelation)
02/2024 - 01/2020
3Hematopoietic Stem Cell Transplantation
01/2022 - 02/2011
3Transplantation
01/2017 - 04/2009
2Erythrocyte Transfusion
01/2020 - 01/2018
1Tonsillectomy
08/2021
1Adenoidectomy
08/2021
1Drug Tapering
01/2021
1Treatment Delay
01/2021
1Splenectomy
06/2015